KCNJ11 activating mutation in an indian family with remitting and relapsing diabetes

Indian Journal of Pediatrics

Volumn 77, Issue 5, 2010, Pages 551-554

  Khadilkar, V V ^a   Khadilkar, A V ^a   Kapoor, R R ^b   Hussain, K ^b   Hattersley, A T ^c   Ellard, S ^c  

^a JEHANGIR HOSPITAL   (India)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

KCNJ11; Neonatal diabetes; Relapse; Remit

Indexed keywords

CELL PROTEIN; GENOMIC DNA; GLIBENCLAMIDE; GLUCOSE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; PROTEIN ABCC8; PROTEIN INS; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIABETOGENESIS; DRUG WITHDRAWAL; FACE DYSMORPHIA; FATHER; FEMALE; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HUMAN; HYPERGLYCEMIA; INDIAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MALE; METABOLIC ACIDOSIS; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NEWBORN; ONSET AGE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RECURRENT DISEASE; SCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIA; INFANT; MALE; MUTATION, MISSENSE; PEDIGREE; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 77956186298     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-010-0062-9     Document Type: Article

References (11)

1. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005; 54: 2503-2513.
2. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004; 350: 1838-1849.
3. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006; 49: 1190-1197.
4. Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007; 56: 1930-1937.
5. Gloyn AL, Reimann F, Girard C, Edghill EL, Proks P, Pearson ER et al. Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum Mol Genet 2005; 14: 925-934.
6. Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, Baevre H et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004; 53: 2713-2718.
7. Proks P, Girard C, Haider S, Gloyn AL, Hattersley AT, Sansom SP et al. A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. EMBO Rep 2005; 6: 470-475.
8. Pearson ER, Flechtner I, Njølstad PR et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355: 467-477.
9. Vaxillaire M, Populaire C, Busiah K, Cavé H, Gloyn AL, Hattersley AT et al. Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. Diabetes 2004; 53: 2719-2722.
10. Edghill E, Flanagan S, Patch AM, Boustred C, Parrish, Shields B et al. Insulin Mutation Screening in 1044 Patients with Diabetes: Mutations in the INS gene are a Common Cause of Neonatal Diabetes but a Rarer Cause of Diabetes Diagnosed in Childhood or Adulthood. Diabetes 2008; 57: 1034-1042.
11. Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic b-cell. Prog Biophys Mol Biol 1989; 54: 87-143.